- Tytuł:
- Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
- Autorzy:
- Źródło:
- Journal of Neurology. :1-5
Czasopismo naukowe